BioAI Health

The AI engine Fit Assessment

Beta

BioAI Health effectively utilizes machine learning for pattern discovery and therapeutic expansion, focusing on biomarker identification to enhance personalized medicine.

Blurb

BioAI Health is a biotech company that uses AI to improve disease diagnosis and predict patient response to therapy.

HQ Location

Goffstown (United States)

Founded

2020

Employees

11 - 50

Total funding raised

$3.50M

Last Funding Event

Seed, $500.00K, April 5, 2024

Smart insights

  • Catherine Msc (Chief People Officer) worked at Lilium as Head of People Business Partnering for 1.5 years (2021 - 2022)
  • Val Miftakhov (Founder & CEO) worked at Google in various roles, including Head of R&D, Google for Work Incubation, for a total of 4 years (2012 - 2016)
  • 6m headcount growth: 25%
  • 1Y headcount growth: 94%
  • Headcount-to-last-round ratio: 5.3 employees/$M
Subspaces
  • Biomarker Identification

Developer of a multi-modal AI platform intended to analyze scalable information and customize services for biopharma clinical biomarker development and diagnostics. The company's platform is based on technologies and services that integrate complex data sets from translational studies and clinical trials to develop machine learning models on multi-omic data, enabling the pharma industry to predict patient response to therapy and drug resistance and solve major challenges in research and development.